Sharon joined the charity in September 2014 following a meeting with Bryn and being truly inspired by the work of FN. Having been in third sector for twelve years, as head of fundraising for two national charities Sharon joined Funding Neuro from Down’s Syndrome Scotland. Prior to the third sector Sharon founded two companies, in the property and innovation sector.
A fundraiser of 20 years’ experience, Paul set up the development programme for the Humanities Division at Oxford University and is a former Director of Development at the Glasgow School of Art. Paul was also earlier a Lecturer in French at Magdalen College, Oxford, and has worked as a self-employed fundraising consultant. He has raised around £50,000,000 to date. Paul joined funding Neuro in April 2016.
Angela has over 20 years accounting and office management experience working within the computing and construction industries and with Glasgow charity Y Sort-it . She joined the charity in 2015 after being inspired by the founder Bryn’s story and Funding Neuro’s unique charity model.
Emma started her career in the charity sector as a volunteer and quickly progressed to become a full-time fundraiser. She’s worked in the sector since 2000 for a variety of causes (Macmillan Cancer Support, Victim Support, RNLI) and was attracted to Funding Neuro unique proposition and place at the forefront of something really revolutionary.
Bryn is the founder of Funding Neuro. He established the charity in order to fund research that will accelerate the cures for neurological medicine. Bryn brings his passion, energy and expertise to the charity and is determined to ensure it achieves its aims. From Northern Ireland, Bryn is a European Patent Attorney and a Chartered Mechanical Engineer. Bryn qualified as a Patent Attorney at Marks and Clerk, and spent 10 years at the company before setting up his own Patent Attorney firm, Creation IP. Since it’s inception, Creation IP has grown to four patent attorneys and has recently seen an expansion into the North American markets.
Bob has been a supporter of Funding Neuro from the beginning, due to his close relationship with Bryn, whom he supported when Bryn was diagnosed 10 years ago. Having retired at the end of last year, Bob decided to join the Board of Funding Neuro, in January 2017. His goal is to help Funding Neuro achieve their highly ambitious but achievable goals. Following a career in the Oil and Gas industry, Bob moved into the intellectual property law, specialising in oil & gas and software. Bob has been a patent attorney for over 30 years with the UK’s largest IP company, Marks & Clerk. Bob was appointed managing partner of Marks and Clerk in 2009 and spent 8 years as their Chairman before retiring at the end of 2016.
David was inspired when hearing the story of Funding Neuro and joined the Board at the beginning of 2016. From Fraserburgh, David gained a degree in Accountancy from the University of Aberdeen before qualifying as a Chartered Accountant with Peat Marwick Mitchell (the forerunner of KPMG) in Aberdeen. Following this, David spent 15 years as Director of Syndicated Lending with the Bank of Scotland in Edinburgh and London. He then took on the role of Chief Operating Officer in Amsterdam for Benelux, with responsibility for all Credit, Operational and Regulatory Risk control and a focus on good governance. During this time, he continued his relationship with Bank of Scotland, sitting on boards for HBoS PLC as a non-UK resident Director. David later returned with his family to Scotland to lead a team of 73 as Area Director Commercial Credit Management for HBoS, managing a portfolio of £350m before moving into Commercial Real Estate with Lloyds Banking Group. David has recently joined the Finance team at an International NGO.
Matt has been actively involved in the development of Funding Neuro and charitable activities from the start and before, where it all started as the Wobbly Williams campaign. He’s embraced the journey with immense enthusiasm and is looking forward to the challenges and successes ahead.
Matt is a Director and Co-Founder of The Social Marketing Gateway, a leading UK behaviour change consultancy. Prior to this he spent over 20 years working in senior marketing roles within a range of private and public sector organisations including central government. He is a Fellow of both the Chartered Institute of Marketing and The Institute of Direct marketing and a Marketing Society Business Leader. Matt is also a member of the Charlton Athletic Community Trust Health Improvement Advisory Board.
Dr Ali joined the Board of Funding Neuro at the end of 2016 and is helping to take forward the exciting plans for the charity. Dr Ali is currently in the process of establishing medical and scientific sub-comittees. He is the Head of Middle East and Asia-Pacific Regions for the Institute for Healthcare Improvement (IHI), he is also a Consultant in Family Medicine and has more than 15 years of clinical experience. Prior to joining IHI, he spent five years at the Abu Dhabi Health Services Co. (SEHA) in Abu Dhabi (UAE), initially as the Director of Clinical Affairs and Quality, Ambulatory Healthcare Services, and then as the Group Quality and Physician Services Director. Previously, Dr. Ali served as a Clinical Director of Primary Care in Lanarkshire, Scotland, and was a GP Principal and partner at Strathaven Health Centre in Lanarkshire. He was also National Clinical Lead for the Royal College of General Practitioners Scotland’s flagship program, Living Better, and served as Co-Chair/Primary Care Lead for the Respiratory Managed Clinical Network in NHS Lanarkshire. Dr. Ali is a graduate of the University of Glasgow and Imperial College, London, and he holds an MBA (with distinction) from the University of Strathclyde. Dr. Ali is a member of distinguished medical societies, including the Royal College of General Practitioners (UK). He is a member of the Faculty of Medical Leadership and Management (UK) and an alumnus of the INSEAD Middle East Health Leadership Programme.